Literature DB >> 6157362

Type II interferon induction and passive transfer depress the murine cytochrome P-450 drug metabolism system.

G Sonnenfeld, C L Harned, S Thaniyavarn, T Huff, A D Mandel, D E Nerland.   

Abstract

Induction of type II interferon by sensitization of mice with Mycobacterium tuberculosis strain BCG and challenge with tuberculin resulted in a depression of the cytochrome P-450 drug metabolism system of the liver. The degree of depression was significantly greater than in mice that were only sensitized to BCG. Cytochrome b5 levels were not affected. In addition, the level of the depression of the cytochrome P-450 system correlated with the levels of type II interferon induced. Passive transfer of exogenous type II interferon preparations also significantly depressed the cytochrome P-450 system. Passive transfer of mock interferon or of normal serum had no effect.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6157362      PMCID: PMC283913          DOI: 10.1128/AAC.17.6.969

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  13 in total

1.  Decreased liver and lung drug-metabolizing activity in mice treated with Corynebacterium parvum.

Authors:  L F Soyka; W G Hunt; S E Knight; R S Foster
Journal:  Cancer Res       Date:  1976-12       Impact factor: 12.701

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Depression of hepatic cytochrome P-450-dependent monooxygenase systems with administered interferon inducing agents.

Authors:  K W Renton; G J Mannering
Journal:  Biochem Biophys Res Commun       Date:  1976-11-22       Impact factor: 3.575

4.  Depression of the hepatic cytochrome P-450 mono-oxygenase system by administered tilorone (2,7-bis(2-(diethylamino)ethoxy)fluoren-9-one dihydrochloride).

Authors:  K W Renton; G J Mannering
Journal:  Drug Metab Dispos       Date:  1976 May-Jun       Impact factor: 3.922

5.  The immunosuppressive effect of type II mouse interferon preparations on antibody production.

Authors:  G Sonnenfeld; A D Mandel; T C Merigan
Journal:  Cell Immunol       Date:  1977-12       Impact factor: 4.868

6.  Production and properties of migration inhibitory factor and interferon in the circulation of mice with delayed hypersensitivity.

Authors:  J S Youngner; S B Salvin
Journal:  J Immunol       Date:  1973-12       Impact factor: 5.422

7.  On the varied biologic effects of interferon.

Authors:  I Gresser
Journal:  Cell Immunol       Date:  1977-12       Impact factor: 4.868

8.  Inhibition of drug-metabolizing enzymes in the rat after Bacillus Calmette-Guérin treatment.

Authors:  D Farquhar; T L Loo; J U Gutterman; E M Hersh; M A Luna
Journal:  Biochem Pharmacol       Date:  1976-07-01       Impact factor: 5.858

9.  Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis.

Authors:  H B Greenberg; R B Pollard; L I Lutwick; P B Gregory; W S Robinson; T C Merigan
Journal:  N Engl J Med       Date:  1976-09-02       Impact factor: 91.245

10.  The deleterious effect of Bordetella pertussis vaccine and poly(rI.rC) on the metabolism and disposition of phenytoin.

Authors:  K W Renton
Journal:  J Pharmacol Exp Ther       Date:  1979-02       Impact factor: 4.030

View more
  1 in total

1.  Influenza vaccination and theophylline pharmacokinetics in patients with chronic obstructive lung disease.

Authors:  B M Stults; P A Hashisaki
Journal:  West J Med       Date:  1983-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.